Sylvia Mangani | Medical Discoveries | Best Researcher Award

Ms. Sylvia Mangani | Medical Discoveries | Best Researcher Award

Ms. Sylvia Mangani | University of Patras | Greece

Sylvia Mangani is a biochemist–biotechnologist and PhD candidate in Biochemistry at the University of Patras, whose research centers on cancer biology, particularly the influence of the extracellular matrix on tumor growth and regulation through 3D cell culture systems. Her academic journey combines strong foundations in biochemistry and biotechnology (BSc, MSc) with advanced experimental and analytical expertise. Her work integrates a broad range of molecular and cellular biology techniques, including quantitative PCR, Western blotting, immunofluorescence, functional assays, and RNA sequencing, complemented by bioinformatics analysis for gene expression and signaling pathway interpretation. Her research has significantly contributed to understanding how 3D cellular microenvironments influence cancer progression, focusing on breast cancer models. She has authored 12 peer-reviewed publications in recognized international journals, with her work cited over 55 times according to Google Scholar, reflecting growing recognition within the scientific community. Her contributions have also supported award-winning synthetic biology initiatives under the iGEM program and have been presented at national and international scientific conferences. She has established productive collaborations with prominent research institutions in Greece and abroad. Notably, she completed a funded Erasmus+ research placement at the University Hospital of Münster, Germany, under the supervision of Prof. Martin Götte, where she engaged in experimental oncology projects exploring cancer cell behavior and matrix interactions. She has also collaborated with the National and Kapodistrian University of Athens on biochemical and molecular analyses within the Laboratory of Biochemistry, Biotechnology, and Molecular Analysis. A member of the Hellenic Society of Biochemistry and Molecular Biology (HSBMB), she actively contributes to the advancement of biochemical and cancer research in Greece and Europe. Her ongoing studies aim to deepen the understanding of tumor–matrix dynamics in breast cancer, offering new insights for therapeutic innovation and cancer model development, positioning her among emerging researchers in molecular oncology.

Profiles: Orcid | Google Scholar | LinkedIn | Research Gate

Featured Publications 

Mangani, S., Piperigkou, Z., Mangani, S., Koletsis, N. E., Koutsakis, C., Mastronikolis, N. S., Franchi, M., & Karamanos, N. K. (2025, August). Principal mechanisms of extracellular matrix‐mediated cell–cell communication in physiological and tumor microenvironments. The FEBS Journal. https://doi.org/10.1111/febs.70207

Mangani, S., Vetoulas, M., Mineschou, K., Spanopoulos, K., Vivanco, M. d. M., Piperigkou, Z., & Karamanos, N. K. (2025, July 15). Design and applications of extracellular matrix scaffolds in tissue engineering and regeneration. Cells, 14(14), 1076. https://doi.org/10.3390/cells14141076

Franchi, M., Masola, V., Onisto, M., Franchi, L., Mangani, S., Zolota, V., Piperigkou, Z., & Karamanos, N. K. (2025, July 7). Ultrastructural changes of the peri-tumoral collagen fibers and fibrils array in different stages of mammary cancer progression. Cells, 14(13), 1037. https://doi.org/10.3390/cells14131037

Karamanos, N. K., Piperigkou, Z., Gourdoupi, C., Mangani, S., & Vivanco, M. d. M. (2025, June 1). Extracellular matrix matters: Matrix-based bioscaffolds in advancing translational cancer research and targeted therapy. American Journal of Physiology-Cell Physiology, 328(6), C1235–C1251. https://doi.org/10.1152/ajpcell.00050.2025

Ciampelli, C., Mangani, S., Nieddu, G., Formato, M., Ioannou, P., Kremmydas, S., Karamanos, N., & Lepedda, A. J. (2025, March). Effects of acidic polysaccharide-enriched extracts from Holothuria tubulosa on two- and three-dimensional invasive breast cancer cell models. Biology, 14(4), 334. https://doi.org/10.3390/biology14040334

Mangani, S., Kremmydas, S., & Karamanos, N. K. (2025, March). Mimicking the complexity of solid tumors: How spheroids could advance cancer preclinical transformative approaches. Cancers, 17(7), 1161. https://doi.org/10.3390/cancers17071161

Diane Harper | Precision Medicine | Distinguished Scientist Award

Prof. Dr Diane Harper | Precision Medicine | Distinguished Scientist Award

Prof. Dr Diane Harper | University of MIchigan | United States

Prof. Dr. Diane M. Harper is a globally recognized physician-scientist, educator, and leader in women’s health, family medicine, and preventive oncology. She earned her SB and SM degrees in Chemical Engineering and Polymerics from the Massachusetts Institute of Technology (MIT), followed by her MD and MPH in Biostatistics/Epidemiology from the University of Kansas Medical School. Complementing her medical and public health expertise, she completed numerous prestigious postgraduate fellowships and executive leadership programs, including the Executive Leadership in Academic Medicine (ELAM) Program, University of Michigan Ross School of Business Leadership Development, and US PHS Primary Care Fellowship in Washington, D.C. Over her distinguished career, Dr. Harper has held senior academic and administrative appointments at leading institutions including Dartmouth College, University of Missouri–Kansas City, University of Louisville, and currently the University of Michigan, where she serves as a Professor of Family Medicine, Obstetrics and Gynecology, and Women’s and Gender Studies, and Affiliate Faculty in Biomedical Engineering. Her interdisciplinary expertise bridges medicine, engineering, and public health to improve women’s health outcomes worldwide. Internationally acclaimed for her pioneering work on Human Papillomavirus (HPV) and cervical cancer prevention, Dr. Harper has been instrumental in the development and clinical validation of HPV vaccines, advancing screening technologies, and establishing evidence-based guidelines for HPV-associated disease management. Her research spans clinical trials, shared decision-making, health equity, and policy reform, emphasizing underserved and physically disabled populations.

Profiles: Google Scholar

Featured Publications

Quinn, J. A., Munoz, F. M., Gonik, B., Frau, L., Cutland, C., Mallett-Moore, T., … & Harper, D. M. (2016). Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine, 34(49), 6047–6056.

Harper, D. M., DeMars, L. R. (2017). HPV vaccines – A review of the first decade. Gynecologic Oncology, 146(1), 196–204.

Tota, J. E., Struyf, F., Merikukka, M., Gonzalez, P., Kreimer, A. R., Bi, D., … & Harper, D. M. (2017). Evaluation of type replacement following HPV16/18 vaccination: pooled analysis of two randomized trials. Journal of the National Cancer Institute, 109(7), djw300.

Gorin, S. S., Jimbo, M., Heizelman, R., Harmes, K. M., & Harper, D. M. (2021). The future of cancer screening after COVID‐19 may be at home. Wiley Periodicals, Inc.

Dykens, J. A., Peterson, C. E., Holt, H. K., & Harper, D. M. (2023). Gender neutral HPV vaccination programs: Reconsidering policies to expand cancer prevention globally. Frontiers in Public Health, 11, 1067299.

Amit Gupta | Drug Development | Best Faculty Award

Dr. Amit Gupta | Drug Development | Best Faculty Award

Dr. Amit Gupta | Chemistry Department Institute of Basic Sciences Dr. B R Ambedkar University Agra | India

Dr. Amit Gupta is a distinguished chemist with an extensive academic background in organic and inorganic chemistry, complemented by a doctoral degree in the study of mercury peroxychromate complexes. With a long teaching career spanning undergraduate to doctoral levels, he has significantly contributed to shaping future researchers and advancing chemical education. His research interests cover coordination chemistry, phytochemistry, and trace metal analysis, with numerous publications and books to his credit. Recognized through awards and active participation in national and international conferences, he continues to make impactful contributions to the fields of chemistry and pharmaceutical sciences.

Academic Profile 

Scopus | Orcid | Google Scholar

Education

Dr. Amit Gupta holds dual Master’s degrees in Organic and Inorganic Chemistry, followed by a Ph.D. in Chemistry from Dr. B. R. Ambedkar University, Agra. His doctoral research focused on the study of mercury peroxychromate and its complexes with nitrogen bases, which provided him with a strong foundation in coordination chemistry and analytical techniques. He has also earned the distinction of being a Fellow of the Indian Council of Chemists (FICC) and has pursued specialized certification in data analysis for life sciences. His academic journey reflects both breadth and depth in chemical sciences, establishing a solid base for his teaching and research career.

Experience

Dr. Gupta has more than two decades of rich teaching experience across undergraduate, postgraduate, and doctoral levels. He has taught B.Sc., M.Sc., M.Phil., and Ph.D. coursework in chemistry and has guided students with academic rigor and research orientation. He has contributed to the academic growth of institutions by teaching core subjects and mentoring research scholars. His long-standing association with the Department of Chemistry at the Institute of Basic Science, Dr. B. R. Ambedkar University, has enabled him to play a pivotal role in shaping future scientists. Alongside teaching, he has authored textbooks in inorganic, organic, and physical chemistry, further extending his impact on the academic community.

Research Interests

Dr. Gupta’s research interests lie in inorganic and coordination chemistry, phytochemistry, and trace metal analysis. He has extensively studied peroxychromates and their complexes, exploring their oxidative behavior and decomposition pathways. His later research expanded into phytochemical screening and the isolation of bioactive compounds from medicinal plants, including studies on flavonoids and antioxidants. He has also investigated trace and heavy metal accumulation in plant systems using modern analytical methods, linking his work to environmental chemistry and human health. His publications reflect a blend of fundamental chemical studies and applied research with multidisciplinary relevance.

Awards and Recognition

Dr. Gupta has been recognized for his academic and research contributions through awards and honors at inter-collegiate and professional platforms. His first-prize achievement in an e-poster competition on nanomaterials and quantum dots highlights his ability to connect advanced concepts in chemistry with innovative presentation. He has actively participated in numerous national and international conferences, workshops, and seminars, showcasing his research and engaging in scholarly exchange. His membership as FICC further underscores his standing in the professional chemistry community, marking him as a respected educator, researcher, and contributor to the advancement of chemical sciences.

Publications

Isolation and characterization of flavonoid glycoside from leaves of Abrus precatorius

Authors: J. Gupta, G. Amit
Journal: International Journal of Chemical Studies
Year: 2014

Determination of trace metals in the leaves of Rauwolfia serpentina by using atomic absorption spectroscopy

Authors: J. Gupta, A. Gupta
Journal: International Journal of Chemical Studies
Year: 2016

Isolation and identification of flavonoid rutin from Rauwolfia serpentina

Authors: J. Gupta, A. Gupta
Journal: International Journal of Chemical Studies
Year: 2015

 Preliminary phytochemical screening of leaves of Moringa oleifera Lam

Authors: J. Gupta, A. Gupta, K. Gupta
Journal: Journal Chemtracks
Year: 2014

Isolation and characterization of flavonoid from leaves of Abrus precatorius

Authors: J. Gupta, A. Gupta
Journal: International Journal of Current Research in Chemistry and Pharmaceutical Sciences
Year: 2016

Studies on the chemical constituents of leaves of Phyllanthus emblica (L.)

Authors: J. Gupta, A. Gupta, A.K. Gupta
Journal: Oriental Journal of Chemistry
Year: 2014

Extraction and identification of flavonoid natural antioxidant in the leaves of Rauwolfia serpentina

Authors: J. Gupta, A. Gupta, A.K. Gupta
Journal: International Journal of Chemical Studies
Year: 2016

Conclusion

Dr. Amit Gupta’s outstanding academic journey, extensive teaching experience, and impactful research contributions make him a distinguished scholar in the field of chemistry. His dedication to advancing scientific knowledge, mentoring future researchers, and publishing widely demonstrates both depth and breadth of expertise. With a proven record of innovation and commitment to excellence, he is a highly deserving candidate for the Best Faculty Award.

FURONG LI | Medical Discoveries | Outstanding Scientist Award

Dr. FURONG LI | Medical Discoveries | Outstanding Scientist Award

Dr. FURONG LI, Shenzhen People’s Hospital, China

Dr. Fu-Rong Li, MD, PhD, is the Director of the Translational Medicine Collaborative Innovation Center at the First Affiliated Hospital (Shenzhen People’s Hospital) of the Southern University of Science and Technology, China. With a prolific academic background in clinical medicine, parasitology, and molecular biology, Dr. Li has made significant contributions in stem cell research, cancer immunotherapy, nanomedicine, and regenerative medicine. Over the course of his distinguished career, he has authored more than 80 peer-reviewed papers and holds several national patents. His pioneering work continues to influence the fields of translational and precision medicine both nationally and internationally.

🧬 Early Academic Pursuits

Dr. Fu-Rong Li embarked on his medical journey with an M.D. from Ningxia Medical College in 1984, followed by a Master’s degree in Parasitic Diseases with a focus on hydatidosis at Lanzhou Medical College in 1991. His academic dedication culminated in a Ph.D. in Molecular and Immune Parasitology from Tongji Medical University in 1999. These formative years laid the groundwork for his enduring contributions to translational medicine, immunotherapy, and stem cell biology. His research curiosity took root early, especially in the intersection of infectious diseases and immune response, which later evolved into a lifelong dedication to stem cell differentiation, regenerative medicine, and cancer immunotherapy.

🏥 Professional Endeavors

Dr. Li currently serves as the Director of the Translational Medicine Collaborative Innovation Center at Shenzhen People’s Hospital, affiliated with the Southern University of Science and Technology (SUSTech). Since 1999, he has held progressive roles from Assistant Professor to Professor, contributing significantly to the evolution of translational medicine in China. His early career included a stint as an Attending Physician in the Department of Digestive Medicine at Ningxia Medical University (1984–1988), followed by senior research and teaching roles at Lanzhou University’s Hydatid Research Laboratory. His professional trajectory showcases his dual capabilities in clinical practice and cutting-edge biomedical research.

🔬 Research Focus and Contributions

Dr. Li is internationally recognized for his pioneering work in stem cell biology, regenerative therapies, cancer diagnostics, and nanomedicine. His research contributions are vast, with over 85 peer-reviewed publications, covering topics like:

  • Differentiation of human induced pluripotent stem cells (iPSCs) into pancreatic β cells.

  • Cancer proteomics and exosomal signaling in lung adenocarcinoma.

  • Nano-immunodiagnostic tools for infectious and oncological diseases.

  • Single-cell analysis of non-coding RNAs in stem cell differentiation and immunity.

  • Development of novel multi-omics frameworks for understanding tumor biology.

His work has been published in prestigious journals such as Stem Cell Research & Therapy, Advanced Science, Cell Death & Disease, and NPJ Genomic Medicine.

🧪 Innovation and Patents

Dr. Li holds nine Chinese national invention patents, reflecting his commitment to translational applications of research. His inventions include:

  • Methods for iPSC to pancreatic cell differentiation via miRNAs.

  • Novel liquid chip-based miRNA detection kits.

  • Dual-labeled gold nanoprobes for diagnostic purposes.

  • Preparation methods for nano-magnetic drug microspheres.

These patents highlight his role as a scientific innovator and entrepreneurial researcher, bridging laboratory discoveries with real-world applications.

🏆 Accolades and Recognition

Dr. Li’s research excellence has earned him national and institutional recognition, especially for his work on diabetic wound healing, tumor immunotherapy, and stem cell engineering. His research has contributed to clinical advancements in personalized medicine and biomaterial-assisted stem cell therapy. He is frequently invited to speak at international conferences, reflecting his status as a leading expert in translational medicine and regenerative biology in China and beyond.

🌍 Impact and Influence

Through mentoring emerging scientists, supervising graduate students, and leading interdisciplinary collaborations, Dr. Li has cultivated a strong academic legacy. He is a bridge between fundamental biology and clinical medicine, influencing drug delivery systems, immunotherapy protocols, and biosensing platforms used globally. His work in lung cancer biology, in particular, has offered insights into cancer metastasis, immune checkpoint modulation, and exosome-mediated signaling pathways—laying the foundation for next-generation immunotherapies.

🔭 Legacy and Future Contributions

As a respected leader in Shenzhen’s biomedical ecosystem, Dr. Fu-Rong Li continues to shape the future of regenerative medicine, nanotechnology, and translational diagnostics. With over four decades of combined clinical and research expertise, he remains committed to advancing therapies for diabetes, cancer, and immune diseases. Looking ahead, Dr. Li is expected to contribute significantly to the integration of AI, single-cell sequencing, and precision medicine for real-time diagnostics and personalized treatment. His multidisciplinary approach ensures that his legacy will influence generations of scientists and physicians to come.

✍️Notable Publications

SLC4A7 suppresses lung adenocarcinoma oncogenesis by reducing lactate transport and protein lactylation

Author:  Haojie Yan , Qian He, Yubiao Gao, Xiaomei He, Haitao Luo, Lijuan Shao, Jun Dong, Furong Li

Journal: International Journal of Oncology .,

Year: 2025

Plant-Derived Extracellular Vesicles as Potential Emerging Tools for Cancer Therapeutics

Author: Lin DingChih-Jung ChangMin-Li LiangKang-Mei DongFu-Rong Li

Journal: Advanced Therapeutics

Year: 2024

Novel DNA Biosensing Platform for Detecting HIV Integrase for Highly Sensitive and Quantitative HIV Detection, Diagnosis, and Therapeutic Monitoring

Author:  Fuming Chen, Jing Wang, Jie Ma, Li Song, Haojie Yan, Feng Wang, Zhengrong Yang, Furong Li

Haishan Jiang | Medical Discoveries | Innovation in Science Award

Dr. Haishan Jiang | Medical Discoveries | Innovation in Science Award 

Dr. Haishan Jiang, Southern Medical University, China

Dr. Haishan Jiang, Chief Physician and Associate Professor at Southern Medical University’s Nanfang Hospital, is a leading expert in neurology, specializing in myopathy, peripheral neuropathy, and rare neurological diseases. As Deputy Director of the Neurology Department and head of the Myopathy and Peripheral Neuropathy subspecialty, he has pioneered gene therapies for SMA and ALS in South China. His research focuses on motor neuron and mitochondrial diseases, as well as gene therapy for rare conditions. Widely recognized, Dr. Jiang has been honored as the “Good Doctor of Guangzhou” and ranks top nationally in physician recommendations for multiple rare diseases.

Author Profile

ORCID

🧑‍🎓 Early Academic Pursuits

Dr. Haishan Jiang embarked on his medical journey with a deep-rooted commitment to understanding the complexities of the human nervous system. With a Doctor of Medicine degree and solid academic grounding, he demonstrated early on a keen interest in neurology, particularly in the areas of myopathy and peripheral neuropathy. His academic path was marked by diligence, a sharp scientific mind, and a profound dedication to uncovering the underlying mechanisms of rare neurological diseases. As a postgraduate supervisor, Dr. Jiang has also shown a strong passion for nurturing the next generation of medical professionals, sharing his knowledge and guiding their research pursuits with patience and precision.

🩺 Professional Endeavors

Currently serving at Nanfang Hospital of Southern Medical University, Dr. Jiang holds several key positions: Chief Physician, Associate Professor, Deputy Director of the Neurology Department, Director of Teaching, and Head of the Myopathy and Peripheral Neuropathy subspecialty. His clinical expertise spans a wide spectrum of neurological disorders, with a particular emphasis on difficult and rare conditions such as motor neuron disease (ALS), mitochondrial encephalomyopathy, and adult-onset spinal muscular atrophy (SMA). Dr. Jiang’s commitment to clinical excellence has led him to establish and lead the Guangdong Province Myopathy and Peripheral Nerve Specialized Alliance, a network aimed at advancing diagnosis, treatment, and research collaboration. Under his leadership, the department ranks among the top two nationally in terms of annual muscle and nerve biopsy volume, solidifying its reputation as a hub for neuromuscular disease care.

🧬 Contributions and Research Focus

Dr. Jiang’s research interests are firmly rooted in neurogenetic disorders, particularly motor neuron diseases (ALS) and mitochondrial disorders. His work seamlessly blends basic science with clinical application, focusing on understanding disease mechanisms and exploring cutting-edge gene therapy approaches. He has spearheaded some of South China’s most advanced gene therapy trials, including the region’s first gene therapy for adult SMA—the fourth such case in the country—and the first ALS gene therapy clinical trial in South China, also the second nationwide. His pioneering research not only contributes to academic knowledge but also offers hope to patients battling previously untreatable conditions. Through his clinical studies, Dr. Jiang is pushing the frontiers of personalized medicine, bringing precision diagnostics and therapy into the mainstream for rare and complex neurological diseases.

🏅 Accolades and Recognition

Dr. Haishan Jiang’s unwavering dedication to medical science and patient care has earned him widespread acclaim. Notably, he was honored as the sixth “Good Doctor of Guangzhou” and selected as part of the ninth batch of “Outstanding Provincial and Municipal Talents Supporting Xinjiang”, a testament to both his clinical excellence and humanitarian spirit. Furthermore, he was recognized by the Good Doctor Network as an “Annual Good Doctor” for his exceptional service in rare disease diagnosis and treatment. His reputation as a leading clinician is reflected in his top rankings in national physician recommendation lists—first place for 13 diseases, including ALS and mitochondrial encephalomyopathy, and second place for 15 others. These accolades not only highlight his expertise but also the trust he has earned from patients and peers alike.

🌍 Impact and Influence

Dr. Jiang’s work has had a transformative impact on neurology in China, particularly in the realm of rare diseases. By advancing the use of gene therapy and establishing regional alliances, he has created a robust infrastructure for collaboration, research, and clinical care. His contributions have significantly improved diagnostic timelines and therapeutic options for patients who previously faced long diagnostic odysseys and limited treatment possibilities. As a teacher and mentor, Dr. Jiang has shaped the careers of countless postgraduate students and young doctors, many of whom now contribute to clinical neurology and research across the country. His influence extends beyond the clinic to policy and advocacy, where he is a strong voice for the rare disease community.

🔬 Legacy and Future Contributions

Dr. Haishan Jiang stands at the forefront of a new era in neurology, where genomics and personalized medicine are reshaping how we understand and treat complex diseases. His legacy is already evident in the systems he has built, the patients he has helped, and the students he has inspired. Looking ahead, Dr. Jiang aims to further expand gene therapy applications, develop innovative treatment protocols, and foster international collaboration in rare disease research. With his continued focus on combining scientific rigor with compassionate care, Dr. Jiang is set to leave a lasting legacy in Chinese and global neurology. His work is not only rewriting the medical narrative for patients with rare conditions but also paving the way for future breakthroughs in neuroscience.

✍️ Publication Top Notes


📘A Multicenter Study of Hereditary Transthyretin Amyloidosis in China

Author: Xujun Chu; Juan Kang; Jingwen Xu; Haishan Jiang; Zhi‐Ying Wu; Qingping Wang; Wei Li; Jia Li;
Journal: Annals of Neurology
Year:2025

📘Knockdown of OPTN modulates miRNA-125b-5p expression via NF-κB pathways in amyotrophic lateral sclerosis

Author: Jian Qin; Ye He; Weiyi Yu; Zhaoyong Zhang; Xiaodan Chen; Yafang Hu; Haishan Jiang
Journal: Archives of Biochemistry and Biophysics
Year: 2025

📘Clinical features of hereditary transthyretin amyloidosis-polyneuropathy with transthyretin Ala97Ser(p.Ala117Ser) mutation in South Mainland China

Author: Yeli Zhu; Jingxian Fan; Xiying Zhu; Wei Li; Zhaoyong Zhang; Hui Zheng; Zhihua Zhou; Lingchao Meng; Ruxu Zhang; Haishan Jiang
Journal: Orphanet Journal of Rare Diseases
Year: 2025